(Q46791653)

25 December 2017

title

A randomized trial of nicotine enemas for active ulcerative colitis (English)

1 reference

25 December 2017

0 references

1

1 reference

25 December 2017

author name string

Gareth A O Thomas

2

1 reference

25 December 2017

John Rhodes

3

1 reference

25 December 2017

John T Green

4

1 reference

25 December 2017

Neil D Hawkes

5

1 reference

25 December 2017

Jill L Swift

6

1 reference

25 December 2017

Emmanuel D Srivastava

7

1 reference

25 December 2017

Brian K Evans

8

1 reference

25 December 2017

Geraint T Williams

9

1 reference

25 December 2017

Robert G Newcombe

10

1 reference

25 December 2017

Edward Courtney

11

1 reference

25 December 2017

Suresh Pillai

12

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

25 December 2017

Clinical Gastroenterology and Hepatology

published in

1 reference

25 December 2017

volume

3

1 reference

25 December 2017

issue

11

1 reference

25 December 2017

page(s)

1107-1114

1 reference

25 December 2017

Non-smoking: a feature of ulcerative colitis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

Cigarette Smoking and Ulcerative Colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

Risk of ulcerative colitis among former and current cigarette smokers

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

A meta-analysis of the role of smoking in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

Does smoking improve colitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

Transdermal nicotine for active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

Transdermal nicotine as maintenance therapy for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

Pharmacokinetics of nicotine carbomer enemas: a new treatment modality for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

Nicotine enemas for active ulcerative colitis—a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

Nicotine tartrate liquid enemas for mildly to moderately active left‐sided ulcerative colitis unresponsive to first‐line therapy: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

Nicotine enemas for treatment of ulcerative colitis: a study of the pharmacokinetics and adverse events associated with three doses of nicotine.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

Classification of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

CONTROLLED TRIAL OF SULPHASALAZINE IN THE TREATMENT OF ULCERATIVE COLITIS.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

Cortisone in ulcerative colitis; final report on a therapeutic trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

The short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

Biopsy studies in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

Rectal aminosalicylate therapy for distal ulcerative colitis: a meta‐analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

Outcome of ulcerative colitis after treatment with transdermal nicotine

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

Distal ulcerative colitis refractory to rectal mesalamine: role of transdermal nicotine versus oral mesalamine

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

Clinical status of ulcerative colitis in patients who smoke

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900849-9

7 January 2021

10.1016/S1542-3565(05)00849-9

Identifiers

DOI

1 reference

25 December 2017

release_e7eej4ceczdcfgk2l4irajfwbu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/e7eej4ceczdcfgk2l4irajfwbu

24 November 2022

mapped directly with Wikidata item

1 reference

25 December 2017